Application Note Biopharma/Pharma Automated Switching between Peptide and Glycan Mapping with the Agilent 1290 Infinity II LC System Increased productivity and flexibility in the characterization of monoclonal antibodies Authors Gerd Vanhoenacker, Aurélie Terrier, Gianni Vandenborre, Pat Sandra, and Koen Sandra…
Klíčová slova
glycan, peptide, originator, trastuzumab, mapping, counts, biosimilar, acquisition, advancebio, response, units, fld, instantpc, cho, rituximab